Sinopharm
1099.HK
#1870
Rank
ยฃ6.85 B
Marketcap
ยฃ2.20
Share price
-0.23%
Change (1 day)
15.12%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : ยฃ8.30 Billion

According to Sinopharm's latest financial reports the company's total debt is ยฃ8.30 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31ยฃ11.32 B42.5%
2021-12-31ยฃ7.94 B3.12%
2020-12-31ยฃ7.70 B28.06%
2019-12-31ยฃ6.01 B-4.64%
2018-12-31ยฃ6.31 B49.02%
2017-12-31ยฃ4.23 B8.34%
2016-12-31ยฃ3.90 B29.65%
2015-12-31ยฃ3.01 B-1.3%
2014-12-31ยฃ3.05 B21.32%
2013-12-31ยฃ2.51 B57.25%
2012-12-31ยฃ1.60 B12.97%
2011-12-31ยฃ1.41 B321.28%
2010-12-31ยฃ0.33 B116.41%
2009-12-31ยฃ0.15 B-4.98%
2008-12-31ยฃ0.16 B2.25%
2007-12-31ยฃ0.16 B30.03%
2006-12-31ยฃ0.12 B